Iris Publishers - Current Trends in Clinical & Medical Sciences (CTCMS)

 If Medical Science could provide a Solution to One Healthcare Issue which would you choose?

Authored by Jack Ray Gallagher


Ischemic heart disease and stroke have remained leading causes of death globally since the turn of this century, accounting for 15.2 million deaths in 2016 [1]. Alzheimer’s disease and related dementias became the fifth leading cause of death in 2016 but were not in the top 10 in 2000, [1] and a study published this month in The Lancet notes that while cardiovascular disease is still the No. 1 cause of death worldwide, cancer has surpassed it in wealthier nations [2]. Would you pick a cure for one of these deadly diseases as the most pressing healthcare issue to solve, or would you give higher priority to development of a spectacular technological advancement such as artificial neural networks with the broad potential to resolve a number of fatal diseases? Before deciding on the healthcare issue most in need of an immediate solution, consider these lines from English poet Samuel Taylor’s “The Rime of the Ancient Mariner” [3]:

Water, water everywhere, / Nor any drop to drink. To be relevant to today’s healthcare issues, this line could be rephrased as: Data, data everywhere, / Nor any know to think.

Like the sailor stranded on a ship surrounded by saltwater that he cannot drink, we are surrounded by inconsistent or spotty realworld data that we cannot use to help find cures and solutions to our most serious diseases and healthcare issues. Our collective task is to determine how to “desalinate” our oceans of real-world data to generate the useful and actionable real-world evidence needed to help resolve critical healthcare issues. The relatively recent emergence of big data in healthcare is an organized attempt to accomplish this onerous task.

Big data analytics potentially offer great benefits to all spectrums of medical and clinical care including improved efficiency and effectiveness of medical treatments, accelerated drug discovery, and enhanced personalization of patient care [4]. Big data in healthcare are derived from such sources as electronic health records (EHRs), claims and other payor records, public records, research studies, government agencies, web and social media, specialized commercial databases (e.g., medical imaging, genomic sequencing), smart phones, and wearable devices. Big data are distinguished from traditional data used in healthcare decision making by their high levels of the “3 Vs”-velocity, volume, and variability-and are far too large to manage with traditional software and/or hardware [5]. Artificial intelligence, machine learning, and natural language processing are among tools that have evolved to help accommodate big-data demands. Compared with other industries, healthcare has been slow to adopt and leverage these and other new analytical technologies, possibly due in part to the special data challenges in healthcare including issues of privacy, security, and standardization [6].

I maintain that curing our big-data woes is as important as curing even the most prevalent deadly disease and could provide the tools to cure or ameliorate many diseases. I also believe scientific journals have a responsibility to highlight the shortcomings of existing big data and to share solutions. Current Trends in Clinical & Medical Sciences is committed to this task.

To read more about this article: https://irispublishers.com/ctcms/fulltext/if-medical-science-could-provide-a-solution-to-one-healthcare-issue-which-would-you-choose.ID.000513.php

Indexing List of Iris Publishers: https://medium.com/@irispublishers/what-is-the-indexing-list-of-iris-publishers-4ace353e4eee

Iris publishers google scholar citations: https://scholar.google.co.in/scholar?hl=en&as_sdt=0%2C5&q=irispublishers&btnG=


Comments

Post a Comment

Popular posts from this blog

Iris Publishers - Current Trends in Clinical & Medical Sciences (CTCMS)

Image
Turning Back the Clock: The Effect of the COVID-19 Response in Sub-Saharan Africa and Other Low- Income Countries Authored by Sanghvi Reema Introduction The COVID-19 pandemic has affected everyone across the world, either through the disease itself or with our response to the disease as healthcare professionals, for the better part of a year. In the matter of a few months, it managed to spread from its little corner of the world to a true pandemic. In response to this global pandemic many affluent nations have instituted lockdown procedures to protect their population, a practice that has been adopted by many low to low- middle income countries (LMICs) as well. Unfortunately, this pandemic does not take place in a vacuum, and individuals can have more than one condition with resultant needs outside their homes. This becomes readily apparent when considering someone receiving medical treatment for a disease such as HIV or TB, who may struggle keeping their treatment appointments. I...
Read more

Iris Publishers - Current Trends in Clinical & Medical Sciences (CTCMS)

Image
Plasma Biochemical Parameters of The Blood of Captive Adult Male and Female Black-Necked Pheasants (Phasianus colchicus), Gray Partridge (Perdix perdix) and Chukar Partridge (Alectoris chukar) in Bulgaria Authored by Slavko Naskov Nikolov Introduction The Black-necked pheasants or Southern Caucasus pheasants (Phasianus col. colchicus), Gray partridge (Perdix perdix) and Chukar partridge (Alectoris chukar) are birds from the order Galliformes, family Phasianidae and native to Europe and Asia. They have been widely introduced as game birds and are one of the world’s most hunted birds [1-2]. Over the last few years, industrial pheasant farms have been developed as a new agricultural activity for commercial production of meat in Europe, and the number of the pheasant population reared each year has increased exponentially [3-4]. Although it is well known that plasma biochemistry is important for medical diagnosis of disease in several bird species, limited information is available for phe...
Read more